Novel multi-color, time-resolved, luminescent lanthanide reporters

新型多色、时间分辨、发光镧系元素报告基因

基本信息

  • 批准号:
    7669032
  • 负责人:
  • 金额:
    $ 18.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-01 至 2009-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Under this Phase I SBIR, Lumiphore will use its proprietary lanthanide technology to develop the `next-generation' of multiplex capable reporter dyes with photophysical properties superior to those currently available. Lumiphore's lanthanide compounds have longer life-times, a larger Stokes shift, and sharper fluorescent peak profiles that conventional organic fluorescent materials, and have greater stability and brightness than commercially available lanthanide- based fluorescence products. Under this SBIR effort, Lumiphore proposes to develop Lumi4"- Tb (Donor) for multi-color time resolved fluorescence. Lumi4"-Tb, originally developed at University of California - Berkeley, is an isophthalamide based macrocyclic chelate that has an exceptionally high quantum yield (60%), extinction coefficient (26,000 M-1cm-1), and long lifetime (2.7 ms) at dilute concentrations in standard aqueous buffer environments. Lumi4TM-Tb has four narrow emission peaks centered at approximately 490nm, 545nm, 590nm, and 620nm. These emission peaks form the basis of the proposed multicolor fluorescent system through energy transfer coupling to a wide range of conventional organic fluorophores (Acceptors) with overlapping excitation maxima. We propose to also vary the linker characteristics between Donor and Acceptors such that emission lifetimes of otherwise identical pairs are discernable. This will create an additional multiplex property in addition to emission wavelength. The proposed research will overcome fundamental limitations of organic fluorescent dyes that have limited the sensitivity, speed, and multiplexing capability and reliability of florescence applications for high throughput screening (HTS) drug discovery, genomic screening, rapid DNA sequencing, clinical diagnostics and fluorescence microscopy. PUBLIC HEALTH RELEVANCE: The proposed research will impact public health by enabling highly multiplexed diagnostic assay formats that combine fast turnaround times and high assay throughput efficiency. These assays will be used in high throughput screening (HTS) drug discovery, genomic screening, rapid DNA sequencing, clinical diagnostics and fluorescence microscopy applications for both basic and applied biomedical research.
描述(由申请人提供):根据第一阶段SBIR,Lumiphore将使用其专有的镧系元素技术开发“下一代”多重报告染料,其物理特性上级于目前可用的报告染料。Lumiphore的镧系化合物具有比常规有机荧光材料更长的寿命、更大的斯托克斯位移和更尖锐的荧光峰轮廓,并且具有比市售的基于镧系的荧光产品更高的稳定性和亮度。在SBIR的努力下,Lumiphore提出开发用于多色时间分辨荧光的Lumi 4”- Tb(供体)。Lumi 4”-Tb最初由加州-伯克利大学开发,是一种基于二甲酰胺的大环螯合物,在标准水性缓冲液环境中稀释浓度下具有极高的量子产率(60%)、消光系数(26,000 M-1cm-1)和长寿命(2.7 ms)。Lumi 4 TM-Tb具有四个窄的发射峰,中心约为490 nm、545 nm、590 nm和620 nm。这些发射峰通过能量转移耦合到具有重叠激发最大值的宽范围的常规有机荧光团(受体)形成了所提出的双荧光系统的基础。我们还建议改变供体和受体之间的连接体特性,使得在其他方面相同的对的发射寿命是可辨别的。这将产生除了发射波长之外的附加的多路复用特性。拟议的研究将克服有机荧光染料的基本局限性,这些局限性限制了高通量筛选(HTS)药物发现,基因组筛选,快速DNA测序,临床诊断和荧光显微镜的荧光应用的灵敏度,速度和多路复用能力和可靠性。公共卫生相关性:拟议的研究将通过实现高度多重的诊断测定格式来影响公共卫生,该格式联合收割机快速周转时间和高测定通量效率。这些分析将用于高通量筛选(HTS)药物发现,基因组筛选,快速DNA测序,临床诊断和荧光显微镜应用的基础和应用生物医学研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nathaniel G Butlin其他文献

Nathaniel G Butlin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

企业绩效评价的DEA-Benchmarking方法及动态博弈研究
  • 批准号:
    70571028
  • 批准年份:
    2005
  • 资助金额:
    16.5 万元
  • 项目类别:
    面上项目

相似海外基金

An innovative EDI data, insights & peer benchmarking platform enabling global business leaders to build data-led EDI strategies, plans and budgets.
创新的 EDI 数据、见解
  • 批准号:
    10100319
  • 财政年份:
    2024
  • 资助金额:
    $ 18.9万
  • 项目类别:
    Collaborative R&D
BioSynth Trust: Developing understanding and confidence in flow cytometry benchmarking synthetic datasets to improve clinical and cell therapy diagnos
BioSynth Trust:发展对流式细胞仪基准合成数据集的理解和信心,以改善临床和细胞治疗诊断
  • 批准号:
    2796588
  • 财政年份:
    2023
  • 资助金额:
    $ 18.9万
  • 项目类别:
    Studentship
Elements: CausalBench: A Cyberinfrastructure for Causal-Learning Benchmarking for Efficacy, Reproducibility, and Scientific Collaboration
要素:CausalBench:用于因果学习基准测试的网络基础设施,以实现有效性、可重复性和科学协作
  • 批准号:
    2311716
  • 财政年份:
    2023
  • 资助金额:
    $ 18.9万
  • 项目类别:
    Standard Grant
Benchmarking collisional rates and hot electron transport in high-intensity laser-matter interaction
高强度激光-物质相互作用中碰撞率和热电子传输的基准测试
  • 批准号:
    2892813
  • 财政年份:
    2023
  • 资助金额:
    $ 18.9万
  • 项目类别:
    Studentship
Collaborative Research: SHF: Medium: A Comprehensive Modeling Framework for Cross-Layer Benchmarking of In-Memory Computing Fabrics: From Devices to Applications
协作研究:SHF:Medium:内存计算结构跨层基准测试的综合建模框架:从设备到应用程序
  • 批准号:
    2347024
  • 财政年份:
    2023
  • 资助金额:
    $ 18.9万
  • 项目类别:
    Standard Grant
Collaborative Research: BeeHive: A Cross-Problem Benchmarking Framework for Network Biology
合作研究:BeeHive:网络生物学的跨问题基准框架
  • 批准号:
    2233969
  • 财政年份:
    2023
  • 资助金额:
    $ 18.9万
  • 项目类别:
    Continuing Grant
FET: Medium: Quantum Algorithms, Complexity, Testing and Benchmarking
FET:中:量子算法、复杂性、测试和基准测试
  • 批准号:
    2311733
  • 财政年份:
    2023
  • 资助金额:
    $ 18.9万
  • 项目类别:
    Continuing Grant
Establishing and benchmarking advanced methods to comprehensively characterize somatic genome variation in single human cells
建立先进方法并对其进行基准测试,以全面表征单个人类细胞的体细胞基因组变异
  • 批准号:
    10662975
  • 财政年份:
    2023
  • 资助金额:
    $ 18.9万
  • 项目类别:
Collaborative Research: BeeHive: A Cross-Problem Benchmarking Framework for Network Biology
合作研究:BeeHive:网络生物学的跨问题基准框架
  • 批准号:
    2233968
  • 财政年份:
    2023
  • 资助金额:
    $ 18.9万
  • 项目类别:
    Continuing Grant
Benchmarking Quantum Advantage
量子优势基准测试
  • 批准号:
    EP/Y004418/1
  • 财政年份:
    2023
  • 资助金额:
    $ 18.9万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了